ACS BrightEdge Golden Ticket to Bakar Labs
Applications are now closed.
The Opportunity
Want to join the innovative community at Bakar Labs and accelerate your solution for oncology?
The American Cancer Society’s BrightEdge and Bakar Labs invite you to apply for a Golden Ticket. The Golden Ticket provides lab bench and core facilities for one year and access to the American Cancer Society BrightEdge team of scientific and industry advisors.
BrightEdge’s mission investment focus areas include:
- Novel oncology biomedical therapeutics and devices.
- Improvement of cancer patient response to therapy.
- Reducing health disparities and cancer patient burden
- Promoting cancer prevention and screening.
The deadline is Friday, March 24, 2023.
Selected applicants will be invited to present their company onsite, in person to a select group of Bakar Labs advisors and ACS BrightEdge leadership on Thursday, May 25.
Timeline
Applications are due by Friday, March 24.
Applicants on the shortlist will be notified by Thursday, April 13.
The shortlist will present to the judging panel in person at Bakar Labs on Thursday, May 25.
The winner(s) will be announced immediately following the pitch session.
Eligibility
This competition is open to life science entrepreneurs who are commercializing, or intend to commercialize, oncology technologies addressing needs in BrightEdge’s areas of interest, as detailed above.
Companies with university affiliation are eligible; so are companies that have no university affiliation.
Teams at the pre-commercial (i.e. not yet incorporated) stage are eligible.
Companies seeking seed-stage through Series A funding are eligible.
We are looking for companies for whom winning a Golden Ticket will significantly impact their ability to advance.
We intend that the winning company (or companies) use this lab space as their primary site of operations.
Apply for the ACS BrightEdge Golden Ticket to Bakar Labs
Applications are now closed.
